Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone vs IVIG in Infection-Related sHLH
NCT07861776Phase 3Not yet recruiting
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Oct 2026
- Primary completion
- Sep 2029
01
Overview
A Phase 3 trial of dexamethasone in haemophagocytic lymphohistiocytosis (HLH), sponsored by Post Graduate Institute of Medical Education and Research. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
haemophagocytic lymphohistiocytosis (HLH)
Beyond the preview
Go deeper on NCT07861776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07861776.